ANI Pharmaceuticals | ANIP - Assets

Stock Price
78.01
Daily Change
-1.57 -1.97%
Monthly
-0.08%
Yearly
30.04%
Q2 Forecast
76.44

ANI Pharmaceuticals reported $1.42B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
ANI Pharmaceuticals USD 1.42B 18.41M Mar/2026
Assertio Holdings USD 319.77M 46M Sep/2025
Aurora Cannabis CAD 775.29M 18.43M Dec/2025
Canopy Growth CAD 1.11B 36.35M Dec/2025
Eli Lilly USD 116.58B 4.1B Mar/2026
Emergent BioSolutions USD 1.82B 69.9M Dec/2023
Heron Therapeutics USD 246.22M 9.66M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
Omeros USD 200.57M 34.59M Jun/2025
Perrigo USD 7.98B 551.9M Mar/2026
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026